Sparebanken Nord-Norge

Sparebanken Nord-Norge

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

About

The most common rounds for this fund are in the range of 10 - 50 millions dollars. The fund usually participates in less than 2 investment rounds per year. The fund's activity peaked in 2009.

The usual method for the fund is to invest in rounds with 7 other investors. Other VCs who often invest in the same rounds are Såkorn Invest Nord, Picasso Kapital, Oystein Rekdal.

Among the most popular investment industries for the fund are Pharmaceutical, Biotechnology. However, the fund’s focus is not limited to this, since there is 1 more area of investment. The average start-up age at the time of investment by this fund is 6-10. Among the most popular portfolio start-up of the fund, is Lytix Biopharma.

Fund Activity

Not operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: snn.no; User name format in descending order of probability: first last, first, last, first_initial last, last first_initial

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing Together

Såkorn Invest Nord, Picasso Kapital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: